New monoclonal antibody for treating cerebral ischemia injury
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has successfully developed a neutralizing monoclonal antibody, 6H2, which targets a harmful protein known to exacerbate damage caused ...
Feb 27, 2024
0
0